ArticleLeukemia research reports2020

Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost.

Giuseppe Milone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.